Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-534-2 | CAS number: 353-50-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://www.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Remarks:
- 5 days of 1-hour exposure
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Remarks:
- Limited details. The test material is not fully characterized
Data source
Reference
- Reference Type:
- publication
- Title:
- Biochemical changes ssociated with toxic exposures to polytetrafluoroethylene pyrolysis products
- Author:
- Scheel L.D, McMillan L., Phipps F.
- Year:
- 1 968
- Bibliographic source:
- Am. Ind. Hyg. Ass. J. 29(1):49-53
Materials and methods
- Principles of method if other than guideline:
- - Principle of test:
repeated exposure to sublethal concentrations of PTFE pyrolysis products
- Short description of test conditions: the treatment consisted in 1-hour exposure during 5 consecutive days, followed by 17 days of post-exposure
- Parameters analysed / observed: body weight, urine parameters, some haematological parameters - GLP compliance:
- not specified
- Remarks:
- Study conducted prior to GLP standards
Test material
- Specific details on test material used for the study:
- The test material is not pure carbonyl fluoride, but polytetrafluoroethylene pyrolysis products considered to contain a majority of gaseous COF2 and other particles (saturated fluorocarbon fragments).
Test animals
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Greenacres Controlled Flora stock
IN-LIFE DATES: From 16-JAN-1967 to 7-FEB-1967
Administration / exposure
- Route of administration:
- inhalation
- Type of inhalation exposure:
- not specified
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION:
The major pyrolysis product resulting from destruction of plastic material above 300°C consists of carbonyl fluoride. All other products were saturated fluorocarbon fragments or carbon dioxide.
TEST ATMOSPHERE
- Brief description of analytical method used: hydrolysable fluoride analysis (no further details)
- the atmosphere consisted of PTFE pyrolysis products (gases, mainly COF2) and particles.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- hydrolyzable fluoride analysed is expressed as ppm carbonyl fluoride
- Duration of treatment / exposure:
- 1-hour exposure each day to PTFE pyrolysis products containing hydrolysable fluoride, expressed as ppm carbonyl fluoride
- Frequency of treatment:
- 5 consecutive days, followed by a 3-day recovery period
Doses / concentrationsopen allclose all
- Dose / conc.:
- 52 ppm
- Remarks:
- day 1
hydrolyzable fluoride analysis expressed as ppm COF2
- Dose / conc.:
- 43 ppm
- Remarks:
- day 2
hydrolyzable fluoride analysis expressed as ppm COF2
- Dose / conc.:
- 29 ppm
- Remarks:
- day 3
hydrolyzable fluoride analysis expressed as ppm COF2
- Dose / conc.:
- 25 ppm
- Remarks:
- day 4
hydrolyzable fluoride analysis expressed as ppm COF2
- Dose / conc.:
- 9 ppm
- Remarks:
- day 5
hydrolyzable fluoride analysis expressed as ppm COF2
- No. of animals per sex per dose:
- 20 in exposed group
10 in control group - Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Dose selection rationale: sublethal concentration
- Post-exposure recovery period in satellite groups: no information - Positive control:
- no
Examinations
- Observations and examinations performed and frequency:
- BODY WEIGHT: Yes
- Time schedule for examinations: on day 1 of treatment, on the last day of treatment (day 5), then on 3 instances during the recovery period (day 3,7 and 17 of the recovery period).
HAEMATOLOGY: Yes, before, during (day 4) and after (day1, 4, 8 and 17) exposure.
- total white blood cells count
- neutrophils
- lymphocytes
CLINICAL CHEMISTRY:
Succinic dehydrogenase activity was examined in the rat kidney and lung, using the method of Shelton and Rice (J. Natl. Cancer INst. 18:117 (1957).
URINALYSIS: Yes
- Time schedule for collection of urine: on day 1 of treatment (after exposure), on the last day of treatment (day 5), then on 3 instances during the recovery period (day 3, 7 and 18 of the recovery period/post exposure).
- Metabolism cages used for collection of urine: Yes, 10 treated and 10 control rats; for a 24-hour urine collection.
- Parameters checked in table 1 were examined: Analysis of glucose, protein, ketones, occult blood, specific gravity, urinary fluoride.
- Animals fasted: Not specified - Sacrifice and pathology:
- GROSS PATHOLOGY: No data
HISTOPATHOLOGY: Some information provided, not fully developped in the publication
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- Signs of toxicity preceeding death showed extreme malaise and weakness.
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- A total of nine animals out of 40 (22%) died during the study (no details on sex):
1 animal was found dead on day 3 of treatment, 3 on day 4, 1 on day 5, 3 on day 1 post-exposure, and 1 on day 3 post-exposure. - Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Decreased body weight (30%) was observed following the 5x1-hr daily exposures.
Recovery was observed 18 days following cessation of treatment. - Haematological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- There was no marked change in total white blood cells.
Following exposure, there was a marked increase in neutrophils, concommittant with an decrease in lymphocytes. Levels partially recovered within the 18-day post-exposure period. This was seen as a sign of acute noninfectious inflammatory response. - Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- Succinic dehydrogenase activity was examined in the rat kidney and in lung.
There was an increased activity in the lung tissue (described as severe pathological change), but activity was inhibited to < 5% of the normal activity in kidney after 5 days of a daily 1-hr exposure. There was a return to normal level after 17 days post-exposure period. - Urinalysis findings:
- effects observed, treatment-related
- Description (incidence and severity):
- There was an increase in urinary fluoride detected after 5 days of 1-hr exposure, then level gradually decreased during the recovery period.
day 1: 3 µg/ml,
day 5: 42 µg/ml
day 18 post-exposure, the fluoride level was still 4 times that of the controls
Protein, glucose and ketones were detected in urine after 5 days of exposure (see Table 1), but were no longer present after 17 days of post-exposure period. - Description (incidence and severity):
- Liver tissue of treated animals showed enlarged nuclei and fatty infiltration of hepatocytes.
- Histopathological findings: neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- Enlarged nuclei and fatty infiltration of the liver cells.
Any other information on results incl. tables
Table 1: Results of urine examination in exposed animals:
parameters | Exposure day 1 | exposure day 5 | post-exposure day 3 | post-exposure day 7 | post-exposure day 18 |
protein | present | present | present | no | no |
glucose | no | present | no | no | no |
ketones | no | present | present | present | no |
blood | no | no | present | no | no |
Applicant's summary and conclusion
- Executive summary:
Five consecutive daily 1-hour exposure of rats to PTFE pyrolysis products caused an increased of urinary fluoride, marked body weight loss, increased succinic dehydrogenase activity in lungs, while it was decreased in liver.
Nine out of 40 exposed animals died during the course of the study.
Inflammatory response was observed during the exposure period as evidenced by decreased neutrophils and increased lymphocytes. Recovery was observed within 17 days after the cessation of exposure.
The level of urinary fluoride returned to lower levels during the post-exposure period, although still 4-fold higher than in controls.
The signs of toxicity are attributed to the exposure to carbonyl fluoride generated during the pyrolysis of PTFE, and which is thought to be hydrolyzed in the body fluids.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)